Skip to main navigation Skip to search Skip to main content

Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes

  • Stacy R. Lindborg
  • , Namita A. Goyal
  • , Jonathan Katz
  • , Matthew Burford
  • , Jenny Li
  • , Haggai Kaspi
  • , Natalie Abramov
  • , Bruno Boulanger
  • , James D. Berry
  • , Katharine Nicholson
  • , Tahseen Mozaffar
  • , Robert Miller
  • , Liberty Jenkins
  • , Robert H. Baloh
  • , Richard Lewis
  • , Nathan P. Staff
  • , Margaret Ayo Owegi
  • , Bob Dagher
  • , Netta R. Blondheim-Shraga
  • , Yael Gothelf
    • Yossef S. Levy, Ralph Kern, Revital Aricha, Anthony J. Windebank, Robert Bowser, Robert H. Brown, Merit E. Cudkowicz
  • Brainstorm Cell Therapeutics
  • University of California at Irvine
  • California Pacific Medical Center
  • Cedars-Sinai Medical Center
  • Brainstorm Cell Therapeutics
  • Pharmalex GmbH
  • Harvard University
  • Mayo Clinic Rochester, MN
  • University of Massachusetts Medical School
  • St. Joseph's Hospital and Medical Center, Phoenix

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes'. Together they form a unique fingerprint.
Sort by

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases